Form 4: Zebra Technologies CFO Nathan Winters Reports Acquisition of Shares and Stock Appreciation Rights

Sentiment:

SEC Form 4 Filing


CFO of Zebra Technologies, Nathan Winters, reports the acquisition of 815 shares of Class A Common Stock and adjustments to existing stock appreciation rights.

Summary

  • On February 5, 2025, Nathan Andrew Winters, CFO of Zebra Technologies, reported acquiring 815 shares of Class A Common Stock.
  • This acquisition resulted in Mr. Winters beneficially owning 12,236 shares of Class A Common Stock.
  • The acquisition was related to previously unreportable performance-based restricted stock (PVRS) granted on May 5, 2022, which vested based on a three-year performance period ending December 31, 2024.
  • The number of shares resulting from the PVRS grant was determined on February 5, 2025, and the PVRS will vest on May 5, 2025.
  • Mr. Winters also holds stock appreciation rights (SARs) with varying exercise prices and vesting schedules.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The CFO acquiring shares suggests confidence in the company. The vesting of PVRS indicates that performance targets were likely met.

Positives

  • The acquisition of shares indicates confidence from the CFO in the company's performance.
  • The vesting of performance-based restricted stock suggests that performance targets were met.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of PVRS on May 5, 2025, is a future event.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

  • Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency regarding insider transactions.
  • Companies like Honeywell, Datalogic, and Intermec (now part of Honeywell) also have executives who regularly file Form 4s to report similar transactions.
  • The vesting of performance-based restricted stock is a common compensation practice among publicly traded companies to align executive incentives with company performance, similar to practices at Cognex and SICK AG.

Stakeholder Impact

  • The reported transactions provide transparency to shareholders regarding insider ownership.
  • The vesting of PVRS may have a positive impact on employee morale, as it indicates that performance goals were achieved.

Next Steps

  • The PVRS shares will vest on May 5, 2025.

Key Dates

DateDescription
May 5, 2022Date of original grant of performance-based restricted stock (PVRS).
December 31, 2024End of the three-year performance period for the PVRS grant.
February 5, 2025Date of transaction and determination of the number of shares resulting from the PVRS grant.
May 5, 2025Vesting date of the PVRS shares.
February 7, 2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.